Protalix BioTherapeutics (PLX) Return on Equity [ROE] (2009 - 2026)
Protalix BioTherapeutics (PLX) reported Return on Equity [ROE] of 27.33% for Q2 2026, up 14.14 percentage points from 13.20% a year earlier and up 0.77 percentage points from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Protalix BioTherapeutics posted Return on Equity [ROE] of -14.44%, down 22.08 percentage points from FY2024.
- By year, Return on Equity [ROE] came in at 7.64% in FY2024 (-64.86 pp) and 72.50% in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q3 2023.
- Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of +3.51 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2025 (a gain of 63.55 percentage points); the low point was Q2 2024 (a drop of 97.49 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 26.56% (Q1 2026), -13.06% (Q4 2025) and 10.49% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 27.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 27.05% |
| Jun 30, 2026 | 27.33% |
| Mar 31, 2026 | 26.56% |
| Dec 31, 2025 | -13.06% |
| Sep 30, 2025 | 10.49% |
| Jun 30, 2025 | 13.20% |
| Mar 31, 2025 | 8.84% |
| Dec 31, 2024 | 7.75% |
| Sep 30, 2024 | -31.49% |
| Jun 30, 2024 | -50.35% |
| Mar 31, 2024 | 21.62% |
| Dec 31, 2023 | 23.15% |
| Sep 30, 2023 | 28.86% |
| Jun 30, 2023 | 47.14% |
| Sep 30, 2021 | -129.60% |
| Jun 30, 2021 | -41.00% |
| Mar 31, 2016 | 819.51% |
| Dec 31, 2012 | -1,717.31% |
| Sep 30, 2012 | -171.60% |
| Jun 30, 2012 | -1,998.29% |
API Access
Protalix BioTherapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();